Biomea Fusion, Inc. (BMEA) NASDAQ

1.37

-0.02(-1.44%)

Updated at June 02 04:00PM

Currency In USD

Biomea Fusion, Inc.

Address

900 Middlefield Road

Redwood City, CA 94063

United States of America (the)

Phone

650 980 9099

Sector

Healthcare

Industry

Biotechnology

Employees

79

First IPO Date

April 16, 2021

Key Executives

NameTitlePayYear Born
Michael J. HitchcockInterim Chief Executive Officer & Director867,9351950
Ramses ErdtmannCo-Founder, President, Chief Operating Officer & Director636,4851963
Caroline Perez- DupontSenior Vice President of Legal0N/A
Heow TanChief Technology & Quality Officer01959
Stephan MorrisChief Development Officer0N/A
Ravi UpasaniExecutive Vice President of Intellectual Property0N/A
Thorsten KirschbergExecutive Vice President of Research01970

Description

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.